Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2024 Financial Results
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) has announced it will release its fourth quarter and fiscal year 2024 financial results on Monday, April 28, 2025, after market hours. The company will host a conference call for investors on Tuesday, April 29, 2025, at 11:00 am ET/8:00am PT.
The company also disclosed a clarification regarding its stock option plan, noting that previous management information circulars for 2023 and 2024 shareholder meetings referenced an outdated version. The correct version, approved by the board in 2022, will be included in the upcoming annual general meeting materials.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) ha annunciato che pubblicherà i risultati finanziari del quarto trimestre e dell'anno fiscale 2024 lunedì 28 aprile 2025, dopo la chiusura dei mercati. L'azienda terrà una conference call per gli investitori martedì 29 aprile 2025 alle 11:00 ET/8:00 PT.
La società ha inoltre fornito una precisazione riguardo al suo piano di opzioni azionarie, segnalando che le precedenti circolari informative della direzione per le assemblee degli azionisti del 2023 e 2024 facevano riferimento a una versione obsoleta. La versione corretta, approvata dal consiglio nel 2022, sarà inclusa nei materiali della prossima assemblea generale annuale.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año fiscal 2024 el lunes 28 de abril de 2025, después del cierre del mercado. La compañía realizará una llamada conferencia para inversores el martes 29 de abril de 2025 a las 11:00 am ET/8:00 am PT.
La empresa también aclaró su plan de opciones sobre acciones, señalando que las circulares informativas de la dirección anteriores para las reuniones de accionistas de 2023 y 2024 hacían referencia a una versión desactualizada. La versión correcta, aprobada por la junta en 2022, se incluirá en los materiales de la próxima junta general anual.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF)는 2025년 4월 28일 월요일 장 마감 후에 2024 회계연도 4분기 및 연간 재무 결과를 발표할 예정이라고 밝혔습니다. 회사는 2025년 4월 29일 화요일 오전 11시 ET/오전 8시 PT에 투자자 대상 컨퍼런스 콜을 진행할 예정입니다.
또한 회사는 주식 매수선택권 계획에 대해 설명하며, 2023년 및 2024년 주주총회용 이전 경영진 정보 서한에 구버전이 언급되었음을 알렸습니다. 2022년에 이사회에서 승인된 올바른 버전이 다가오는 연례 주주총회 자료에 포함될 것입니다.
Aurora Spine (TSXV : ASG) (OTCQB : ASAPF) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'exercice 2024 le lundi 28 avril 2025, après la clôture des marchés. La société organisera une conférence téléphonique pour les investisseurs le mardi 29 avril 2025 à 11h00 ET/8h00 PT.
La société a également apporté une précision concernant son plan d'options d'achat d'actions, indiquant que les circulaires d'information de la direction pour les assemblées des actionnaires de 2023 et 2024 faisaient référence à une version obsolète. La version correcte, approuvée par le conseil d'administration en 2022, sera incluse dans les documents de la prochaine assemblée générale annuelle.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2024 am Montag, den 28. April 2025, nach Börsenschluss veröffentlichen wird. Das Unternehmen veranstaltet am Dienstag, den 29. April 2025, um 11:00 Uhr ET/8:00 Uhr PT eine Telefonkonferenz für Investoren.
Das Unternehmen gab außerdem eine Klarstellung zu seinem Aktienoptionsplan bekannt und wies darauf hin, dass frühere Management-Informationsschreiben für die Aktionärsversammlungen 2023 und 2024 eine veraltete Version enthielten. Die korrekte Version, die 2022 vom Vorstand genehmigt wurde, wird in den Unterlagen zur bevorstehenden Hauptversammlung enthalten sein.
- None.
- None.
CARLSBAD, California, April 23, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced it will issue its financial results for the fourth quarter and fiscal year ended December 31, 2024, on Monday, April 28, 2025, after market hours. Management will host a conference call for investors on Tuesday, April 29, 2025 at 11:00 am ET/8:00am PT to discuss the results with investors.
Additionally, the Company wishes to clarify that the management information circulars issued in connection with its 2023 and 2024 annual meetings of shareholders inadvertently referenced a prior version of the Company’s stock option plan. The updated plan, which has been in effect since its approval by the board in 2022, included certain amendments that were not described in the circulars. The Company intends to include the correct version of the plan in the materials for its upcoming annual general meeting of shareholders, details of which will be announced in due course.
Fourth Quarter and Fiscal Year 2024 Conference Call Details
Date and Time: Tuesday, April 29, 2025, at 11:00 a.m. ET / 8:00 a.m. PT
Call-in Information: Interested parties can access the conference call by dialing (844) 861-5497 or (412) 317-5794.
Webcast: Interested parties can access the conference call via a live webcast, which is available via the following link: https://app.webinar.net/ZVY76PMx3gp.
Replay: A teleconference replay of the call will be available until May 6, 2025, at (877) 344-7529 or (412) 317-0088, replay access code 5737353. Additionally, a replay of the webcast will be available at https://app.webinar.net/ZVY76PMx3gp for 90 days.
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
Investor Contact
Adam Lowensteiner
Lytham Partners
(646) 829-9702
asapf@lythampartners.com
FAQ
When will Aurora Spine (ASAPF) release its Q4 and fiscal 2024 earnings?
How can investors join Aurora Spine's (ASAPF) Q4 2024 earnings call?
What is the issue with Aurora Spine's (ASAPF) stock option plan disclosure?
How long will Aurora Spine's (ASAPF) Q4 2024 earnings call replay be available?
